By staff writers

April 9, 2019 -- Cerebrovascular imaging software developer iSchemaView has received approval from Israel's Ministry of Health medical device regulation unit (AMAR) for the use of its Rapid imaging platform in Israel.

As a result, hospitals and clinics in Israel can now utilize the artificial intelligence (AI)-based stroke assessment platform's capabilities for automated analysis of CT perfusion, MR, CT angiography, and Alberta Stroke Program Early CT Score (ASPECTS), according to the company.

Copyright © 2019

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking